as on
| Source : BSE
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
0.17%
Downside
6.57%
Upside
52 Week's Low
52 Week's High
48.81%
Downside
82.22%
Upside
Market Stats | |
Previous Close | ₹59.49 |
Open | ₹62.45 |
Volume | 1,543.00 |
Upper Circuit | ₹62.46 |
Lower Circuit | ₹56.52 |
Day's Low | ₹58.5 |
Day's High | ₹62.45 |
52 Week Low | ₹30 |
52 Week High | ₹106.78 |
Returns % | |
1 Month Return | + 2.71 % |
3 Month Return | + 1.66 % |
1 Year Return | + 85.96 % |
3 Year Return | + 8.76 % |
5 Year Return | + 183.29 % |
Check Aspira Pathlab & Diagnostics Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹61.23 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
25.53
Return on capital employed (ROCE)
0Industry PE ratio
54.03
Beta (LTM)
0.49
P/B Ratio
6.11
Dividend Yield
0PEG Ratio
7.36
Quarterly Earnings Growth YOY
740
EPS (TTM)
0Sector
Healthcare
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Track how Aspira Pathlab & Diagnostics Ltd P/E has moved over time to understand its valuation trends.
Aspira Pathlab & Diagnostics Ltd in the last 5 years
Lowest (-433.33x)
November 29, 2024
Today (25.53x)
August 21, 2025
Industry (54.03x)
August 21, 2025
Highest (124.02x)
March 24, 2025
Today’s Price to Earnings Ratio: 25.53x
Get the annual and quarterly financial summary of Aspira Pathlab & Diagnostics Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Aspira Pathlab & Diagnostics Ltd.
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 740% since last year same period to ₹0.42Cr in the Q1 2025-2026. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated -38.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Aspira Pathlab & Diagnostics Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 18.39% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 81.61% | 0.00 | |
Others | 0% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Aspira Pathlab & Diagnostics Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 61.23 | 36.66% | 0.00 | -3 | 13 | |
NA | 26.34 | -16.78% | 0.00 | 1 | 24 | |
NA | 100.30 | 40.11% | 0.59 | 10 | 199 | |
NA | 81.85 | 7.43% | 0.00 | 4 | 33 | |
NA | 9.55 | 20.44% | 0.00 | -2 | 4 |
Latest news and events in one place to help you make informed investing decisions in Aspira Pathlab & Diagnostics Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 1 Year
In the last 1 year, Aspira Pathlab has outperformed top 5 stocks with highest market-cap in Healthcare Facilities & Services
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 231.6% return, outperforming this stock by 222.8%
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 81.61% of holdings in Jun 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 18.39% of holdings in Jun 2025 quarter
Price Dip
In the last 7 days, Aspira Pathlab stock has moved down by -4.1%
Organisation | Aspira Pathlab & Diagnostics Ltd |
Headquarters | Mumbai |
Industry | Healthcare |
CEO | Haseeb Drabu |
E-voting on shares | Click here to vote |
Aspira Pathlab & Diagnostics Ltd share price today stands at ₹58.6, Open: ₹62.45, Previous Close: ₹59.49, High: ₹62.45, Low: ₹58.5, 52 Week High: ₹106.78, 52 Week Low: ₹30 as on .
To buy Aspira Pathlab & Diagnostics Ltd shares, you need to follow these steps:
Today's traded volume of Aspira Pathlab & Diagnostics Ltd is 1,543.00. Which means that 1,543.00 shares of Aspira Pathlab & Diagnostics Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Aspira Pathlab & Diagnostics Ltd is ₹61.23 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Aspira Pathlab & Diagnostics Ltd’s 52 week high is ₹106.78 and 52 week low is ₹30. The current share price of Aspira Pathlab & Diagnostics Ltd is ₹58.6, which is -45.12% down from its 52 week high and 95.33% up from its 52 week low.